home / stock / negxf / negxf short
Short Information | Nexgenrx Inc (OTCMKTS:NEGXF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 37,984 |
Total Actual Volume | 47,584 |
Short Trends | |
---|---|
Cover Days | 0 |
Short Days | 17 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 1,899 |
Average Short Percentage | 80.22% |
Is there a NEGXF Short Squeeze or Breakout about to happen?
See the NEGXF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-20-2024 | $0.2 | $0.2 | $0.2 | $0.2 | 8,000 | 8,000 | 100% |
01-02-2024 | $0.1767 | $0.1804 | $0.1804 | $0.1767 | 5,500 | 5,000 | 90.91% |
10-19-2023 | $0.1933 | $0.1933 | $0.1933 | $0.1933 | 600 | 600 | 100% |
08-30-2023 | $0.211 | $0.211 | $0.211 | $0.211 | 300 | 300 | 100% |
04-14-2023 | $0.2437 | $0.2437 | $0.2437 | $0.2437 | 150 | 150 | 100% |
04-12-2023 | $0.2417 | $0.2417 | $0.2417 | $0.2417 | 100 | 100 | 100% |
04-05-2023 | $0.2569 | $0.2569 | $0.2569 | $0.2569 | 125 | 125 | 100% |
09-26-2022 | $0.2495 | $0.2495 | $0.2495 | $0.2495 | 200 | 100 | 50% |
08-05-2022 | $0 | $0.2747 | $0 | $0 | 70 | 70 | 100% |
04-12-2022 | $0.26 | $0.26 | $0.26 | $0.26 | 6,500 | 2,500 | 38.46% |
01-26-2022 | $0.3217 | $0.3217 | $0.3217 | $0.3217 | 100 | 100 | 100% |
12-06-2021 | $0.37 | $0.3441 | $0.37 | $0.3441 | 10,000 | 7,500 | 75% |
02-09-2021 | $0.2238 | $0.224 | $0.224 | $0.2238 | 5,000 | 5,000 | 100% |
02-03-2021 | $0.224 | $0.2223 | $0.224 | $0.2223 | 5,000 | 2,500 | 50% |
01-27-2020 | $0.1481 | $0.1481 | $0.1481 | $0.1481 | 920 | 920 | 100% |
11-13-2018 | $0.2229 | $0.2229 | $0.2229 | $0.2229 | 2,657 | 2,657 | 100% |
08-07-2018 | $0.2226 | $0.2226 | $0.2226 | $0.2226 | 2,197 | 2,197 | 100% |
06-18-2018 | $0.2012 | $0.2012 | $0.2012 | $0.2012 | 165 | 165 | 100% |
News, Short Squeeze, Breakout and More Instantly...
TORONTO, ON / ACCESSWIRE / April 5, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its annual financial results for the financial year ended December 31, 2023, with continued revenue growth to $3,573,751 for the quarter and $13,846,329 year to date. Annual EBITDA was $...
TORONTO, ON / ACCESSWIRE / December 20, 2023 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce that a dividend in the amount of one-half of one cent per share ($0.005) has been declared in respect of all of its outstanding common shares and series 1 preferred shares. This divi...
TORONTO, ON / ACCESSWIRE / November 23, 2023 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its interim financial results for the third quarter ended September 30, 2023, with continued revenue growth to $3,390,174 for the quarter and $10,272,578 year to date. The quarterl...